Nialipin 400 mg By Cardiovascular Research Overview & Drug Interactions
Check For Interactions With Nialipin 400 mg
Supplement: Nialipin 400 mg by Cardiovascular Research
Nialipin 400 mg Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Niacin
Niacin, also known as vitamin B3, is a water-soluble vitamin found in a variety of foods, including meat, poultry, fish, and fortified grains. It plays a variety of roles in the body, including in the metabolism of carbohydrates, fats, and proteins. It is also necessary for the production of energy in the body and in the synthesis of different hormones. Niacin deficiency is rare in developed countries, however, supplementation has been shown to have several positive benefits. For example, it can reduce the risk of diabetic neuropathy (i.e., nerve pain) and has been shown effective for treating some types of high cholesterol (extended-release niacin is used as a prescription drug in the United States for this purpose). There is a multitude of niacin forms available as dietary supplements, including NADH, niacinamide, and nicotinamide riboside, all with different properties.
See More Information Regarding Niacin| Ingredient Group | Niacin |
|---|---|
| Category | vitamin |
- Nicotinic Acid
Drugs that interact with Nialipin 400 mg by Cardiovascular Research
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Tablet(s)
|
| Maximum serving Sizes: |
2 Tablet(s)
|
| Servings per container | 60 |
| UPC/BARCODE | 696859131639 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Niacin |
400 mg
|
Niacin |
2000%
|
| Other Ingredients: |
Microcrystalline Cellulose
Hydroxypropylmethylcellulose
Garanzo Bean Flour
Stearic Acid
Silicon Dioxide
Ethylcellulose
Food Glaze
|
|---|
Label Statments:
| FDA Statement of Identity |
- Dietary Supplement
|
|---|---|
| Formulation |
- Nialipin is well-tolerated by sensitive individuals.
- Gluten free, casein free
|
| Suggested/Recommended/Usage/Directions |
- Hypersensitive individuals are advised to start with one tablet prior to increasing dosage. Each sustained-release tablet is designed to release niacin over a period of 6 to 8 hours. Do not cut tablets in half.
- Directions
Take or or two tablets daily, or as directed by a physician.
|
| Precautions |
- Do not take niacin unless recommended by and taken under the supervision of a physician if you have any of the following conditions: gallbladder disease, gout, arterial bleeding, glaucoma, diabetes, impaired liver function, peptic ulcer, or if you are pregnant or lactating.
|
| General Statements |
- Ecological Formulas
|
| Formula |
- Sustained-release niacin
|
| FDA Disclaimer Statement |
- This product has not been evaluated by the FDA. This product is not intended to diagnose, cure, treat or prevent any disease.
|
Brand Information
See all products by this brand
| Manufactured exclusively for | |
|---|---|
| Name | Cardiovascular Research, LTD. |
| Street Address | 1061-B Shary Circle |
| City | Concord |
| State | CA |
| ZipCode | 94518 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.